Antiangiogenic agents are compounds which prevent angiogenesis in vitro and/or in vivo. Angiogenesis inhibitors may be endogenous or synthetic; others are obtained from diet, for example resveratrol.

Antiangiogenic Products

Product Name / Activity
5121 3PO
PFKFB3 inhibitor; antiangiogenic
4706 Borrelidin
Antiangiogenic; inhibits threonyl-tRNA synthetase
5029 CHC
Monocarboxylic acid transport (MCT) inhibitor; displays anti-angiogenic activities
1495 Combretastatin A4
1768 Fumagillin
1629 Herbimycin A
Antiangiogenic. Inhibits Src family kinases and Hsp90
1461 Linomide
Immunomodulator with antiangiogenic properties
1807 2-Methoxyestradiol
Antiangiogenic and apoptotic agent
4664 Obtustatin
Potent and selective α1β1 inhibitor; antiangiogenic
2710 OGT 2115
Antiangiogenic. Heparanase inhibitor
4733 P005091
USP7 inhibitor; antiangiogenic
4744 P11
Potent antagonist of αvβ3-vitronectin interaction; antiangiogenic
2954 PX 12
Thioredoxin-1 inhibitor; attenuates HIF-1α
4885 R 1530
Multi-RTK inhibitor; inhibits angiogenesis
1418 Resveratrol
Cyclooxygenase inhbitor
0652 Thalidomide
Antiangiogenic. Inhibits TNF-α synthesis
1098 Tranilast
3101 XRP44X
Antiangiogenic; microtubule depolymerization agent

Quick Order

Find multiple products by catalog number

divider line

VEGF Pathway & Anti-Angiogenic Therapy

Written by N. Ferrara & Y. Crawford

Angiogenesis Poster

A summary of antiangiogenic therapies targeting the VEGF pathway and the mechanisms of therapy resistance.

divider line

New Product Guide


Highlights 130 new products added in the first half of 2015. View PDF today.

divider line

Bio-Techne Events

EMBO 2015

The 6th EMBO Meeting 2015

September 5 - 8, 2015

Birmingham, UK